These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1314027)

  • 21. Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma).
    Reimer G
    Rheum Dis Clin North Am; 1990 Feb; 16(1):169-83. PubMed ID: 2406806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Masking of nontumorous antigens for development of human tumor nucleolar antibodies with improved specificity.
    Freeman JW; Busch RK; Ross BE; Busch H
    Cancer Res; 1985 Nov; 45(11 Pt 2):5637-42. PubMed ID: 3902213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune response.
    Ulanet DB; Torbenson M; Dang CV; Casciola-Rosen L; Rosen A
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12361-6. PubMed ID: 14519847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rabbit antibodies to nucleoli of Novikoff hepatoma and normal liver of the rat.
    Busch RK; Daskal I; Spohn WH; Kellermayer M; Busch H
    Cancer Res; 1974 Sep; 34(9):2362-7. PubMed ID: 4367290
    [No Abstract]   [Full Text] [Related]  

  • 25. Autoantibodies to survivin in patients with chronic hepatitis and hepatocellular carcinoma.
    Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Watanabe N
    Autoimmunity; 2005 Sep; 38(6):445-8. PubMed ID: 16278150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of hepatocellular-carcinoma-associated antigens and autoantibodies by serological proteome analysis combined with protein microarray.
    Li L; Chen SH; Yu CH; Li YM; Wang SQ
    J Proteome Res; 2008 Feb; 7(2):611-20. PubMed ID: 18161940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Definition of tumor-associated antigens in hepatocellular carcinoma.
    Stenner-Liewen F; Luo G; Sahin U; Tureci O; Koslovski M; Kautz I; Liewen H; Pfreundschuh M
    Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):285-90. PubMed ID: 10750667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma.
    Zhang JY; Chan EK; Peng XX; Tan EM
    J Exp Med; 1999 Apr; 189(7):1101-10. PubMed ID: 10190901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nucleolar antigens in human cancer cells.
    Busch H; Busch RK; Chang PK
    Cardiovasc Res Cent Bull; 1981; 19(3):61-99. PubMed ID: 7044546
    [No Abstract]   [Full Text] [Related]  

  • 30. [Active immunization: circulating antibodies in experimental hepatoma].
    Más M; Chordi A
    Rev Med Univ Navarra; 1975; 19(1):41-7. PubMed ID: 188089
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of tumor-associated antigens by using SEREX in hepatocellular carcinoma.
    Wang K; Xu X; Nie Y; Dai L; Wang P; Zhang J
    Cancer Lett; 2009 Aug; 281(2):144-50. PubMed ID: 19304375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings: Correlation of serum levels of hepatoma D23 antigen, antibody and immune complexes with growth of transplanted tumours.
    Price MR; Bowen JG
    Br J Cancer; 1974 Aug; 30(2):183. PubMed ID: 4370885
    [No Abstract]   [Full Text] [Related]  

  • 33. Autoantibodies to the major nucleolar phosphoprotein B23 define a novel subset of patients with anticardiolipin antibodies.
    Li XZ; McNeilage LJ; Whittingham S
    Arthritis Rheum; 1989 Sep; 32(9):1165-9. PubMed ID: 2789047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antinuclear, antinucleolar, and anticytoplasmic antibodies in patients with malignant melanoma.
    Thomas PJ; Kaur JS; Aitcheson CT; Robinson WA; Tan EM
    Cancer Res; 1983 Mar; 43(3):1372-80. PubMed ID: 6337706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The fibrillarin (Scl-34) autoantibody in systemic scleroderma].
    Kühn G; Jarzabek-Chorzelska M; Blaszczyk M; Chorzelski TP; Jablonska S
    Dermatol Monatsschr; 1990; 176(1):19-26. PubMed ID: 2178987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indirect immunofluorescence studies of proliferating cell nuclear antigen in nucleoli of human tumor and normal tissues.
    Chan PK; Frakes R; Tan EM; Brattain MG; Smetana K; Busch H
    Cancer Res; 1983 Aug; 43(8):3770-7. PubMed ID: 6134581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating immune complexes in the sera and ascites of hepatocellular carcinoma or chronic hepatitis patients.
    Chen YM; Hu CP; Wong FH; Chen PH; Tsai YT; Lee SD; Liu JD; Chang CM
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Feb; 19(1):34-45. PubMed ID: 3028719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of five antigens in hepatocellular carcinoma.
    Thung SN; Gerber MA; Sarno E; Popper H
    Lab Invest; 1979 Aug; 41(2):101-5. PubMed ID: 88543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies to IGF-II mRNA binding protein p62 and overexpression of p62 in human hepatocellular carcinoma.
    Zhang J; Chan EK
    Autoimmun Rev; 2002 May; 1(3):146-53. PubMed ID: 12849008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis.
    Azzaroli F; Colecchia A; Lodato F; Trerè D; Bacchi Reggiani ML; Festi D; Prati GM; Accogli E; Casanova S; Derenzini M; Roda E; Mazzella G
    Aliment Pharmacol Ther; 2006 Jul; 24(1):129-36. PubMed ID: 16803611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.